Second-line chemotherapy in small cell lung cancer
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Reference44 articles.
1. Etoposide and cisplatin in previously treated small-cell lung cancer: clinical trial and in vitro correlates;Batist;J. Clin. Oncol.,1986
2. Small-cell carcinoma of lung: reinduction therapy after late relapse;Batist;Ann. Intern Med.,1983
3. Mechanism of multidrug resistance;Bradley;Biochim. Biophys. Acta,1988
4. The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP-16-213, doxorubicin and vincristine (VPAV) for small cell lung cancer;Cantwell;Eur. J. Cancer Clin. Oncol.,1988
5. Mitomycin-C, etoposide, cisplatin and hexamethylmelamine as a second-line regimen in lung cancer;Chahinian;Am. J. Clin. Oncol.,1984
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chemotherapy for small cell lung cancer: a comprehensive review;Oncology Reviews;2012-04-02
2. Oral second- and third-line lomustine–etoposide–cyclophosphamide chemotherapy for small cell lung cancer;Lung Cancer;2010-02
3. The clinical observation of combined chemotherapy of irinotecan and cisplatin in the treatment of relapsed advanced small cell lung cancer;The Chinese-German Journal of Clinical Oncology;2008-09
4. Combination chemotherapy with paclitaxel and ifosfamide as the third-line regimen in patients with heavily pretreated small cell lung cancer;Lung Cancer;2007-10
5. Small cell lung cancer;Annals of Oncology;2006-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3